Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1-Reference-Cited by-同舟云学术

Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1

Published:2016-07-25 Issue:9 Volume:17 Page:1067-1074
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Garcia-Beltran Wilfredo F,Hölzemer Angelique,Martrus Gloria,Chung Amy W,Pacheco Yovana,Simoneau Camille R,Rucevic Marijana,Lamothe-Molina Pedro A,Pertel Thomas,Kim Tae-Eun,Dugan Haley,Alter Galit,Dechanet-Merville Julie,Jost Stephanie,Carrington Mary,Altfeld Marcus

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.3513.pdf

Reference55 articles.

1. Parham, P., Norman, P.J., Abi-Rached, L. & Guethlein, L.A. Variable NK cell receptors exemplified by human KIR3DL1/S1. J. Immunol. 187, 11–19 (2011).

2. Vivier, E. & Ugolini, S. Natural killer cells: from basic research to treatments. Front. Immunol. 2, 18 (2011).

3. Rajalingam, R. Human diversity of killer cell immunoglobulin-like receptors and disease. Korean J. Hematol. 46, 216–228 (2011).

4. Min-Oo, G., Kamimura, Y., Hendricks, D.W., Nabekura, T. & Lanier, L.L. Natural killer cells: walking three paths down memory lane. Trends Immunol. 34, 251–258 (2013).

5. Waggoner, S.N., Cornberg, M., Selin, L.K. & Welsh, R.M. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481, 394–398 (2011).

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ITAM‐based receptors in natural killer cells;Immunological Reviews;2024-02-27

2. Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response;BMC Medical Genomics;2024-01-27

3. Allogeneic Natural Killer Cells: An Additional Player in Human Immunodeficiency Virus Cure Approaches?;The Journal of Infectious Diseases;2024-01-11

4. Harnessing natural killer cell effector function against cancer;Immunotherapy Advances;2023-12-21

5. Killer instincts: natural killer cells as multifactorial cancer immunotherapy;Frontiers in Immunology;2023-11-28